1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Obsessive Behavior: new trials by email Literature Review of Obsessive Behavior trials Research Report on Obsessive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy AFQ056, Placebo - Patient Diagnosed With OCD and Resistant to SSRI Treatment, Failed SSRI Over 12 Weeks at Appropriate Doses | Phase 2 | Terminated | Novartis Pharmaceuticals | 50 | 2013-11-01 | 2017-01-02 |
Compulsive Behavior (1) · Obsessive-Compulsive Disorder (1)
Anxiety Disorders (1) · Behavior (1) · Behavioral Symptoms (1) · Impulsive Behavior (1) · Mental Disorders (1)
mavoglurant (1)
Bulgaria (1) · Czechia (1) · Germany (1) · Switzerland (1) · United States (1)